Immunotherapy
157 articles
A New Immunotherapy Drug to Make Chemotherapy More Effective for Metastatic Pancreatic Cancer
Researchers are testing a new immunotherapy drug to make standard chemotherapy more effective for metastatic pancreatic cancer.
Two New Immunotherapy Trials Aim to Make Therapy More Effective
Two clinical trials in the Lustgarten Foundation’s Clinical Accelerator are testing different combinations of immunotherapy.
I Wanted Immunotherapy!
When Daniel Miller was diagnosed with pancreatic cancer he knew he didn’t want chemotherapy—he wanted immunotherapy!
Exercise Helps Boost Immune System and Immunotherapy Treatment
Dr. Emma Kurz is part of a research team that has found that exercise can help make immunotherapy more effective for pancreatic cancer.
Combining Immunotherapy and Targeted Therapy for Pancreatic Cancer
Researchers are combining immunotherapy and targeted therapy in a clinical trial for pancreatic cancer patients on platinum-based chemotherapy.
Chemotherapy, Immunotherapy, and Radiation for Locally Advanced Pancreatic Cancer
A clinical trial combines chemotherapy, immunotherapy, including a pancreas vaccine, and SBRT to stop locally advanced pancreatic cancer.
Immunotherapy for Advanced Pancreatic Cancer and Other Solid Tumors
Researchers are testing the use of tumor-infiltrating lymphocytes, a type of immunotherapy, against advanced pancreatic cancer.
New Immunotherapy Strategy Aimed at High-Risk Population
Dr. Neeha Zaidi is the lead investigator of an immunotherapy trial using a vaccine for people at high risk for pancreatic cancer.
Targeting Mutant KRAS with Immunotherapy
Dr. Beatriz Carreno explains how her team is targeting the KRAS mutation with a pancreatic cancer vaccine to make the immune system work against cancer.
CRISPR-Engineered Immunotherapy for Metastatic GI Tract Cancers
CRISPR technology is used as part of an immunotherapy clinical trial for metastatic pancreatic cancer and other GI cancers.
Testing the Safety of an Immunotherapy Combination After Surgery
A new clinical trial tests the safety of a monoclonal antibody and personalized cancer vaccine plus chemotherapy after surgery to remove pancreatic cancer.
Testing the Effectiveness of Immunotherapy Added to a New Drug Combination
Researchers are testing a drug combination that adds immunotherapy to standard drugs used to treat pancreatic cancer and an antimalarial drug.
Immunotherapy to Attack a Common Pancreatic Cancer Mutation
Researchers are testing a type of immunotherapy to attack a variant of the KRAS mutation; KRAS mutations occur in almost all pancreatic cancers.
Taking Nothing For Granted
After Whipple surgery and chemoradiation, Susan Zbacnik had molecular profiling, genetic testing, and joined an Immunotherapy clinical trial.
Collaborative Multi-Center Immunotherapy Trial Targets CD40 and PD-1
Dr. Mark O’Hara outlines a collaborative clinical trial of two immunotherapy agents–a checkpoint inhibitor and a monoclonal antibody–plus standard chemotherapy.